DK3439668T3 - Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose - Google Patents

Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose Download PDF

Info

Publication number
DK3439668T3
DK3439668T3 DK17779973.1T DK17779973T DK3439668T3 DK 3439668 T3 DK3439668 T3 DK 3439668T3 DK 17779973 T DK17779973 T DK 17779973T DK 3439668 T3 DK3439668 T3 DK 3439668T3
Authority
DK
Denmark
Prior art keywords
small molecule
cystic fibrosis
airway surface
human cystic
lung epithelia
Prior art date
Application number
DK17779973.1T
Other languages
Danish (da)
English (en)
Inventor
Martin D Burke
Katrina A Muraglia
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of DK3439668T3 publication Critical patent/DK3439668T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK17779973.1T 2016-04-08 2017-04-10 Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose DK3439668T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662320111P 2016-04-08 2016-04-08
US201662320795P 2016-04-11 2016-04-11
PCT/US2017/026806 WO2017177228A1 (en) 2016-04-08 2017-04-10 Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia

Publications (1)

Publication Number Publication Date
DK3439668T3 true DK3439668T3 (da) 2024-09-02

Family

ID=60001496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17779973.1T DK3439668T3 (da) 2016-04-08 2017-04-10 Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose

Country Status (9)

Country Link
US (2) US20190083517A1 (enExample)
EP (1) EP3439668B1 (enExample)
JP (1) JP7041961B2 (enExample)
AU (1) AU2017248394B2 (enExample)
DK (1) DK3439668T3 (enExample)
ES (1) ES2983639T3 (enExample)
FI (1) FI3439668T3 (enExample)
PT (1) PT3439668T (enExample)
WO (1) WO2017177228A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2983639T3 (es) 2016-04-08 2024-10-24 The Board Of Trustees Of The Univ Illinois Restauración mediada por moléculas pequeñas de la fisiología de la superficie de las vías respiratorias en epitelios pulmonares humanos de fibrosis quística
DK3694526T3 (da) * 2017-10-11 2025-02-03 Univ Illinois Genotype-agnostisk redning af cystisk fibrose med småmolekylære bicarbonatkanaler
CA3250825A1 (en) 2022-03-21 2023-09-28 Cystetic Medicines Inc PROSTHETIC COMPOSITIONS WITH ION CHANNELS COMPRISING AMPHOTEROTIN B LIPID-COATED CRYSTALS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
CA2194049A1 (en) 1994-06-28 1996-01-11 Georgi Stankov Novel clinical uses of polyene macrolides
TWI249408B (en) * 2003-12-10 2006-02-21 Ind Tech Res Inst New antifungal formulation and manufacturing method thereof
AU2005251745A1 (en) 2004-06-04 2005-12-22 The Regents Of The University Of California Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
HUE031951T2 (en) * 2006-10-10 2017-08-28 Jina Pharmaceuticals Inc Aqueous systems for lipid-based drug compounds; preparations, processes and their use
WO2009006311A2 (en) * 2007-06-29 2009-01-08 Wisconsin Alumni Research Foundation Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
RU2481100C2 (ru) * 2009-10-16 2013-05-10 Лайфкеа Инновейшнз Пвт. Лтд. Новая лекарственная форма для лечения грибковой инфекции
CN105848721B (zh) * 2013-10-07 2019-08-23 伊利诺伊大学评议会 具有提高的治疗指数的两性霉素b衍生物
US20180015115A1 (en) * 2014-11-04 2018-01-18 The Board Of Trustees Of The University Of Illinois Restoring physiology with small molecule mimics of missing proteins
ES2983639T3 (es) 2016-04-08 2024-10-24 The Board Of Trustees Of The Univ Illinois Restauración mediada por moléculas pequeñas de la fisiología de la superficie de las vías respiratorias en epitelios pulmonares humanos de fibrosis quística

Also Published As

Publication number Publication date
AU2017248394A1 (en) 2018-11-22
US20190083517A1 (en) 2019-03-21
US11850256B2 (en) 2023-12-26
EP3439668B1 (en) 2024-06-19
JP7041961B2 (ja) 2022-03-25
FI3439668T3 (fi) 2024-09-05
ES2983639T3 (es) 2024-10-24
AU2017248394B2 (en) 2023-02-23
WO2017177228A1 (en) 2017-10-12
EP3439668A4 (en) 2019-12-18
PT3439668T (pt) 2024-08-12
US20210393661A1 (en) 2021-12-23
EP3439668A1 (en) 2019-02-13
JP2019510788A (ja) 2019-04-18

Similar Documents

Publication Publication Date Title
IL261987B (en) Modulators of cystic fibrosis transmembrane conductance regulator
EP3504988A4 (en) COMBUSTION-FREE FLAVOR INHALER
IL263030A (en) Pegylated liposomes and methods of use
DK3929207T3 (da) Peptid fttftvt til anvendelse i behandling af fibrose
EP3091955A4 (en) Portable massage roller
BR112015023328A2 (pt) compostos de piridazinona e métodos para o tratamento de fibrose cística
AU201616623S (en) Personal vaporiser
HRP20241144T8 (hr) Stabilne formulacije lipida i lipozoma
EP3520561A4 (en) EFFICIENT USER-LEVEL ARCHITECTURE
DK2672957T3 (da) Hidtil ukendt sammensætning til behandling af cystisk fibrose
PL4209238T3 (pl) Nebulizator oraz wkład
EP3379337A4 (en) Conductive roll
GB201609692D0 (en) Improvements in and relating to network configuration
EP3357685A4 (en) COSMETIC FILM AND COSMETICS PLATE
EP3358075A4 (en) FOIL AND LAMINATE BODY
EP3189472A4 (en) Managing registration of user identity using handwriting
DK3149153T3 (da) Forøgelse af lipidproduktion i olieholdig gær
DK3116570T3 (da) Inhalator
EP3178461A4 (en) Ultra-thin massaging core and massager using same
PL3655079T3 (pl) Jednodawkowy inhalator proszkowy
MA42266A (fr) Agent thérapeutique contre la fibrose
PL3443854T3 (pl) Inhalator aromatu
DK3439668T3 (da) Småmolekylemedieret genoprettelse af luftvejsoverfladefysiologi i lungeepiteler ved human cystisk fibrose
IL249402A0 (en) Aminoglycosides for the treatment of Rett's syndrome
EP3307898A4 (en) CELLULOSIC BIOFUEL AND BY-PRODUCTS